切換帳號

  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 登入

全站搜尋

台灣泌尿科醫學會E-School
  • 登入
  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 到官網
  • Home
  • 到官網
  • Home
知識庫
  • 目錄總覽
  • 文件總覽
  • 最新討論
目錄 / 資料夾
  • 學術活動與演講
    • 年會
      • 2025半年會
        • 摘要
      • 2024年會
        • 摘要
      • 2024半年會
        • 摘要
      • 2023年會
        • 摘要
      • 2023半年會
        • 摘要
      • 2022年會
        • 摘要
      • 2021年會
        • 摘要
      • 2021半年會
        • 摘要
      • 2020年會
        • 摘要
      • 2020半年會
        • 摘要
      • 2019年會
        • 摘要
      • 2019半年會
        • 摘要
      • 2018年會
        • 摘要
      • 2018半年會
        • 摘要
      • 2017年會
        • 摘要
      • 2017半年會
        • 摘要
      • 2016年會
        • 摘要
      • 2016半年會
        • 摘要
      • 2015年會
        • 摘要
  • 新手指南與FAQ
  1. 知識庫
  2. 最新上傳

最新上傳
(
  • 熱門
)

最新上傳

(
  • 熱門
)
MP02-10: Anterior fibromuscular stroma preserved prostate enucleation could achieve better continent control in larger first day voiding volume after Foley removal
2023-01-03
MP02-09: The ultrasound-guided extracorporeal shock wave lithotripsy with minimal X-ray exposure to treat the urolithiasis in Taiwan
2023-01-03
MP02-08: The efficacy of transvaginal ultrasound-guided BoNT-a external sphincter injection in female patients with underactive bladder syndrome
2023-01-03
MP02-07: Continuous cytokine-receptor binding blockings mediated by controlled release of peptide can alleviate outlet obstruction-induced bladder fibrosis in mice
2023-01-02
MP02-06: Comparison of expulsive rate of distal ureteral stone between Tamsulosin, Silodosin, and Tadalafil : A meta-analysis and systematic review
2023-01-02
MP02-04: The real-world outcome with Enzalutamide in Asian men with metastatic castrate-resistant prostate cancer treated in China Medical University Hospital
2023-01-02
MP02-03: Focal high-intensity focused ultrasound (HIFU) therapy in low to intermediate-risk prostate cancer: preliminary outcomes in a single center
2023-01-02
MP02-02: UBE2C functions as a potential oncogene by promoting bladder tumor progression and lymphatic metastasis
2023-01-02
MP02-01: Outcome of minimally invasive radical cystectomy in Taipei Tzu Chi Hospital
2023-01-02
MP01-10: MCTP1 promotes SNAI1-driven neuroendocrine differentiation and epithelial-to-mesenchymal transition of prostate cancer enhancement by ZBTB46/FOXA2/HIF1A
2023-01-02
MP01-09: Tumor suppressive functions of hsa-miR-34a on cell cycle, migration, and protective autophagy in bladder cancer
2023-01-02
MP01-08: Phillyrin regulates prostate cancer migration and mitochondrial biogenesis through AMPK pathway
2023-01-02
MP01-07: Comparison of dosage and clinical outcome of Ra-223 in mCRPC: Real world data from single center
2023-01-02
MP01-06: Plasmacytoid urothelial carcinoma : TCVGH experience
2023-01-02
MP01-05: Investigation of the role of MTHFD2 in urothelial carcinoma
2023-01-02
MP01-04: Higher albumin levels are associated with better ADT responses in men with metastatic hormone sensitive prostate cancer
2023-01-02
MP01-03: The impact of tumor location on intravesical recurrence in patients with upper tract urothelial carcinoma after radical nephroureterectomy
2023-01-02
MP01-02: Predict factors of the renal function after nephroureterectomy with bladder cuff excision
2023-01-02
MP01-01: Risk factors of unsuccess outcome of the re-adjustable male sling system for stress urinary incontinence following radical prostatectomy
2023-01-02
PD04-6: The prevalence and co-infection rate of gonorrhea and chlamydia in patients with urethritis and treatment outcome
2023-01-02
PD04-5: Type 2 diabetes mellitus, but not hypertension or hyperlipidemia, increases the risk of balanitis and in middle age men
2023-01-02
PD04-4: One-stage buccal mucosal urethroplasty for traumatic anterior urethral stricture: a single- center retrospective cohort analysis
2023-01-02
PD04-3: An updated systematic review and network meta analysis comparing open, laparoscopic and robotic assisted sacrocolpopexy for managing pelvic organ prolapse
2023-01-02
PD04-2: Is endovascular venous intervention an option for treating patients with veno-occlusive dysfunction?
2023-01-02
  • <
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • >
/ 127
地址:台北市 11051 信義區基隆路一段432號6樓之1, 電話:02-2729-0819, 傳真:02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw